Send Inquiry

Request To Call Back

Memantine Hydrochloride Tablets IP

Get a Price/Quote

MOQ : 100 Packs

Memantine Hydrochloride Tablets IP Specification

Indication
Moderate to severe Alzheimers disease, Dementia associated with Alzheimers

Origin of Medicine
India

Brand Name
Memantine Hydrochloride Tablets IP

Life Span
24 Months

Salt Composition
Memantine Hydrochloride

Pacakaging (Quantity Per Box)
30 Tablets

Packaging Type
Blister pack (Box)

Dosage Form
Oral tablet

Drug Type
Allopathic

Ingredients
Memantine Hydrochloride

Physical Form
Tablets

Function
NMDA receptor antagonist for neuroprotection

Recommended For
Treatment of Alzheimers disease and moderate to severe dementia

Dosage
As directed by physician, typically starting at 5 mg once daily, titrated up to 20 mg per day

Dosage Guidelines
Follow physicians instructions; do not self-medicate

Suitable For
Adults, Geriatric Patients

Quantity
30 tablets per box

Storage Instructions
Store below 30C in a dry place, protect from light and moisture

Side Effects
Dizziness, headache, confusion, constipation

Regulatory Status
Scheduled H drug in India

Contraindications
Known hypersensitivity to Memantine or any excipients

Prescription Status
Prescription only (Rx)

Administration Route
Oral

Color
White or off-white

Compliance Standard
IP (Indian Pharmacopoeia)

Marketed by
As per packaging details

Safety Information
Not advised for use in children; consult doctor for renal/hepatic impairment

Shape
Round, film-coated tablet

Batch Number
As printed on blister pack

MRP
As per retail packaging

Strength
5 mg or 10 mg per tablet (confirm pack label)

Memantine Hydrochloride Tablets IP Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Memantine Hydrochloride Tablets IP

Introducing the acclaimed Memantine Hydrochloride Tablets IP-your masterful solution for managing moderate to severe Alzheimer's disease and dementia associated with Alzheimer's. This famed, hot-selling formulation, with resplendent efficacy, features white or off-white, round, film-coated tablets in 5 mg or 10 mg strengths (confirm with pack label). Administered orally and available strictly via prescription (Rx), this high-quality NMDA receptor antagonist complies with Indian Pharmacopoeia (IP) standards. Each box contains 30 tablets in a secure blister pack, crafted for optimal shelf-life. Buy now for trusted neuroprotection and enhanced patient outcomes.

Surface Application, Special Features & Proper Usage Directions

Memantine Hydrochloride Tablets IP deliver precise neuroprotection benefits on the neural application surface, ensuring masterful support for cognitive function in dementia patients. This pharmaceutical stands out with its easy-to-administer, round, film-coated tablet design, optimized for adult and geriatric use. For best outcomes, follow your physician's directions precisely-begin with 5 mg once daily, titrating up as advised. Do not self-medicate. Its resplendent efficacy makes it a favoured choice for advanced Alzheimer's care.

FOB Port, Export Markets & Certifications-A Trusted Global Solution

Memantine Hydrochloride Tablets IP are handed over via major Indian FOB ports upon confirmed purchase order, ensuring smooth international trade. These acclaimed tablets are widely handed over to markets across Asia, Africa, and the Middle East, making them a renowned global solution. Certified under the Indian Pharmacopoeia (IP) and adhering to Scheduled H regulatory standards, every consignment is traced by batch number for assured quality. Purchase with confidence-reliability and compliance are guaranteed upon every handover.

FAQ's of Memantine Hydrochloride Tablets IP:

Q: How should Memantine Hydrochloride Tablets IP be administered?

A: Memantine Hydrochloride Tablets IP should be taken orally, starting typically at 5 mg once daily, with the dose titrated up to a maximum of 20 mg per day as directed by your physician. Always follow your doctor's instructions and never self-medicate.

Q: What conditions are Memantine Hydrochloride Tablets IP recommended for?

A: These tablets are recommended for the treatment of moderate to severe Alzheimer's disease and dementia associated with Alzheimer's. They function as NMDA receptor antagonists to support cognitive health and neuroprotection.

Q: When should I avoid taking Memantine Hydrochloride Tablets IP?

A: Avoid using this medication if you have a known hypersensitivity to Memantine or any tablet excipients. It's also not advised for children and should be used cautiously in patients with renal or hepatic impairment-always consult your healthcare provider first.

Q: What are the potential side effects of using Memantine Hydrochloride Tablets IP?

A: Some individuals may experience dizziness, headache, confusion, or constipation while taking Memantine Hydrochloride Tablets IP. Speak to your physician if you notice any concerning symptoms.

Q: Where are Memantine Hydrochloride Tablets IP manufactured and exported?

A: These tablets are produced in India, complying with IP standards, and exported to multiple regions, including Asia, Africa, and the Middle East, via major Indian FOB ports as part of a secure and timely supply process.

Q: What makes this product a hot-selling choice among traders and suppliers?

A: Memantine Hydrochloride Tablets IP are highly sought after due to their resplendent effectiveness, adherence to stringent regulatory standards, and robust global distribution network. Their proven efficacy in Alzheimer's care makes them favored among healthcare professionals.

Tell us about your requirement